Angelina Jolie and the One Percent
By Gayle Sulik,
Scientific American
| 05. 20. 2013
After learning that she had inherited a mutation on one of the so-called breast cancer genes, actress Angelina Jolie decided to have a double mastectomy to reduce her risk of developing breast cancer. She also plans to have her ovaries removed to reduce her risk of ovarian cancer. It may sound like a drastic measure, but mutations on the breast cancer genes (BRCA1 and BRCA2) increase the overall risk of developing several cancers, including prostate, pancreatic, testicular, ovarian, and breast. On average, a woman with a BRCA1 mutation (the one Jolie has) has a 65 percent risk of developing breast cancer and a 39 percent risk of ovarian cancer by the age of 70. Jolie’s mother died of ovarian cancer at age 56, after ten years of living with the disease. Jolie explained her medical decision in an
op-ed in
The New York Times, saying that she decided to be proactive and to minimize the risk as much [she] could.
Since the Angelina Jolie story broke, there’s been a flurry of discussion about risks, medical interventions, access to medical...
Related Articles
By Abigail Ruhman , Association of Heath Care Journalists | 07.10.2026
The words reporters use and how publications tell stories can play a significant role in challenging ideas that are harmful to people with disabilities, according to a panel at HJ26.
Leading journalists and disability advocates said reporters and editors...
By Oscar Lopez, The Guardian | 07.19.2026
Diogo Amaro met his future husband, Loup, in Paris and from the first date, he made one thing clear: he wanted to have children.
“Right off the bat, I was like: ‘If I’m going to be in a relationship with...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
